The traumatic brain injury market size has grown strongly in recent years. It will grow from $2.72 billion in 2024 to $2.98 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to improved trauma care, rehabilitation therapies, concussion awareness, military and sports research.
The traumatic brain injury market size is expected to see strong growth in the next few years. It will grow to $4.16 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to neuroprotective agents, telemedicine and remote monitoring, individualized treatment plans, neuroinflammation research. Major trends in the forecast period include neurorehabilitation advances, mild tbi and concussion management, biomarker and imaging research, cognitive and emotional support.
The increasing number of road injuries is expected to drive the growth of the traumatic brain injury (TBI) market in the coming years. Road injuries refer to any physical harm or damage resulting from accidents on roads, highways, or other transportation routes. Traumatic brain injuries are commonly caused by road accidents and can lead to a variety of physical and cognitive challenges for those affected. TBI treatment helps individuals recover from brain injuries caused by such incidents, improving physical recovery, reducing complications, and enhancing cognitive function. For example, in November 2024, a report published by the U.S. Department of Transportation revealed that in 2022, 42,514 people lost their lives on U.S. roads, marking an increase of over 10% compared to 2020. As a result, the rise in road injuries is driving the growth of the traumatic brain injury market.
The growing incidence of sports injuries is set to drive the trajectory of the traumatic brain injury market in the coming years. Sports injuries encompass physical trauma or harm sustained during sports, exercise, or athletic activities. Traumatic brain injuries (TBIs) can result from sports injuries when there is a forceful impact or jolt to the head or body during athletic endeavors. These injuries can arise from various causes, including head impacts, falls, collisions, and repetitive head blows. For instance, according to the 2022 statistics published by the National Safety Council, a US-based nonprofit safety advocate, injuries related to exercise and exercise equipment increased in 2022, with a total of 3,631,970 cases compared to 3,231,885 in 2021. Consequently, the surge in sports injuries is a key driver of growth in the traumatic brain injury market.
Leading companies in the traumatic brain injury (TBI) market are developing innovative treatments and diagnostic tests, such as the VIDAS TBI (GFAP, UCH-L1), to address the evolving needs of patients. Ongoing research and development of new therapies and diagnostic tools aim to enhance outcomes and improve the quality of life for individuals affected by TBI. For example, in October 2023, bioMérieux, a France-based in vitro diagnostics company, launched the VIDAS TBI (GFAP, UCH-L1) blood test. This test supports the assessment of patients with mild traumatic brain injury (mTBI) by using a unique combination of brain biomarkers - GFAP and UCH-L1. The test serves as an accurate and objective tool to help reduce unnecessary head CT scans for mTBI patients and alleviate Emergency Department (ED) congestion by predicting the absence of acute intracranial lesions (ICL) following head trauma.
In April 2022, Koninklijke Philips N.V., a Netherlands-based healthcare technology company, established a partnership with Prisma Health. This collaboration with Prisma Health aims to enhance patient care by addressing data integration and maximizing the utility of patient data. The agreement supports Prisma Health in its pursuit of enterprise interoperability while fostering innovation in corporate imaging solutions. Prisma Health is a US-based non-profit healthcare organization that offers a comprehensive outpatient brain injury program with rehabilitative services.
Major companies operating in the traumatic brain injury market are Pfizer Inc., Medtronic PLC, Eli Lilly and Company, Stryker Corporation, Elekta AB, Integra LifeSciences Holdings Corp., Natus Medical Inc., Nihon Kohden Corporation, Raumedic AG, Qure.ai, Compumedics Ltd., Synaptive Medical Inc., BrainScope Company Inc., Neuren Pharmaceuticals Limited, SanBio Co. Ltd., Soterix Medical Inc., Inteprod LLC, BioDirection Inc., InfraScan Inc., NanoDx Inc., NeuroTrauma Sciences, Oculogica Inc., PathMaker Neurosystems Inc., Pinteon Therapeutics Inc., Vivonics Inc., Neural Analytics Inc., ReNetX Bio Inc., Sana Health Inc., Abliva AB, QuesGen Systems Inc.
North America was the largest region in the traumatic brain injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in traumatic brain injury report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the traumatic brain injury market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The traumatic brain injury market consists of revenues earned by entities by providing services such as rehabilitation services, medical care, counseling, psychological support, case management and recreational therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The traumatic brain injury market also includes sales of assistive devices, cognitive rehabilitation tools, communication aids and safety equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Traumatic brain injury (TBI) refers to an injury resulting from the sudden application of external force to the head, leading to brain damage. Common causes of traumatic brain injuries encompass incidents like falls, motor vehicle accidents, sports-related injuries, violence, or military combat. Treating traumatic brain injuries necessitates a comprehensive approach that encompasses medical interventions, rehabilitation, and cognitive therapy.
The primary devices employed in addressing traumatic brain injuries encompass computed tomography, X-ray machines, various imaging devices, magnetic resonance imaging devices, monitoring equipment, and others. Computed tomography is a medical imaging technique that utilizes specialized X-ray equipment to generate detailed cross-sectional images of the body. Diagnostic centers, hospitals, and other healthcare facilities employ treatment techniques such as intracranial pressure (ICP) monitoring and measuring the partial pressure of oxygen in brain tissue (PbrO2).
The traumatic brain injury market research report is one of a series of new reports that provides traumatic brain injury market statistics, including traumatic brain injury industry global market size, regional shares, competitors with a traumatic brain injury market share, detailed traumatic brain injury market segments, market trends and opportunities and any further data you may need to thrive in the traumatic brain injury industry. This traumatic brain injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
Traumatic Brain Injury Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on traumatic brain injury market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for traumatic brain injury? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The traumatic brain injury market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Device: Computed Tomography; X-Ray; Imaging Devices; Magnetic Resonance Imaging Devices; Monitoring Devices; Other Devices2) By Technique: Intracranial Pressure (ICP) Monitoring; Partial Pressure Of Oxygen In Brain Tissue (PbrO2)
3) By End-Use: Diagnostic Centers; Hospitals; Other End-Uses
Subsegments:
1) By Computed Tomography: Standard CT Scans; CT Angiography2) By X-Ray: Skull X-Ray; Cervical X-Ray
3) By Imaging Devices: Ultrasound Imaging; PET Scans
4) By Magnetic Resonance Imaging Devices: Closed MRI; Open MRI
5) By Monitoring Devices: Intracranial Pressure Monitors; EEG Monitors
6) By Other Devices: Neuropsychological Testing Devices; Portable Brain Injury Assessment Devices
Key Companies Mentioned: Pfizer Inc.; Medtronic plc; Eli Lilly and Company; Stryker Corporation; Elekta AB
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Traumatic Brain Injury market report include:- Pfizer Inc.
- Medtronic plc
- Eli Lilly and Company
- Stryker Corporation
- Elekta AB
- Integra LifeSciences Holdings Corp.
- Natus Medical Inc.
- Nihon Kohden Corporation
- Raumedic AG
- Qure.ai
- Compumedics Ltd.
- Synaptive Medical Inc.
- BrainScope Company Inc.
- Neuren Pharmaceuticals Limited
- SanBio Co. Ltd.
- Soterix Medical Inc.
- Inteprod LLC
- BioDirection Inc.
- InfraScan Inc.
- NanoDx Inc.
- NeuroTrauma Sciences
- Oculogica Inc.
- PathMaker Neurosystems Inc.
- Pinteon Therapeutics Inc.
- Vivonics Inc.
- Neural Analytics Inc.
- ReNetX Bio Inc.
- Sana Health Inc.
- Abliva AB
- QuesGen Systems Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | March 2025 |
Forecast Period | 2025 - 2029 |
Estimated Market Value ( USD | $ 2.98 Billion |
Forecasted Market Value ( USD | $ 4.16 Billion |
Compound Annual Growth Rate | 8.6% |
Regions Covered | Global |
No. of Companies Mentioned | 31 |